Palatin Technologies, Inc.

PTN Healthcare Biotechnology

In the quarter to June 2026, revenue fell 14.1%, EPS fell 276.3% and free cash flow grew 34.2%, each against the same quarter a year earlier.

6.02 0.47 −7.24%
Market cap
$11.6M
P/E
0.0×
Fwd P/E
0.2×
Dividend yield
—
F-score
n/a
Altman Z
−67.72
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

131.87% (378.68%) (297.25%) (877.60%)
ROA
(79.90%) (86.59%) (73.72%) (142.11%)
ROIC
0.00% 0.00% (942.30%) 0.00%
Return on Tangible Assets
(1,802.78%) (85.59%) (60.18%) (128.68%)
Average Days of Receivables
189.00 52.63 59.77 8.33
Free Cash Flow per Share
(16.37) (6.27) (3.83) (4.81)
Free Cash Flow
(15.91) (15.92) (14.99) (13.59)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 30 Sep 2026